Navigation Links
Genetic Variant Slows AIDS Progression
Date:11/23/2009

HIV patients who have it take longer to get sick, study finds

MONDAY, Nov. 23 (HealthDay News) -- Scientists report that a genetic variation appears to play a major role in slowing disease progression in HIV-infected patients.

In fact, those with the variation appear to take years longer to develop AIDS and die of complications of the disease.

"We're honing in on factors that vary across individuals that make a person more or less susceptible to HIV, in terms of how rapidly someone develops the disease," said study co-author Mary Carrington, a senior principal investigator at the U.S. National Cancer Institute.

However, this new knowledge won't translate into immediate benefits for patients with HIV.

AIDS remains a major killer in many parts of the world, but HIV -- the virus that causes it -- doesn't affect infected people the same way. "People progress to AIDS at hugely different rates," Carrington explained. "Some people progress within a year, while some have been infected for 20 years and still control the virus and don't have the disease."

It appears that three factors affect how the disease strikes a person, she said. One is the environment: the world in which a person lives. Another is the patient's genetic makeup. And the third is the genetic makeup of the virus itself.

In the study, published in the Nov. 22 online edition of Nature Genetics, Carrington and colleagues looked at genetic and medical records for hundreds of HIV-infected men. They were trying to see if genetic variations affected how the men fared.

The researchers found that a variation linked to higher levels of a protein known as HLA-C boosted the men's ability to avoid progressing to AIDS. It appeared to delay both the progression to AIDS and to death by years, Carrington said.

The genetic variation makes it easier for the immune system to kill cells that have been infected with the virus, she said. It does this by allowing immune cells to gain greater access to the infected cells, she explained.

Carrington said this genetic variation isn't related to another gene-related trait that makes some people virtually immune to HIV.

The study "hints at ways we might ultimately develop a vaccine or immune-based therapies that could modify or maybe even prevent the development of HIV disease," said Rowena Johnston, vice president of research with the Foundation for AIDS Research in New York City.

"The finding that a single piece of DNA can be strongly associated with something as complex as the control of HIV soon after infection is especially intriguing, not least because we know that early control of infection sets the stage for the entire course of the disease," Johnston noted.

What's next? The ultimate goal, Carrington said, is "to have a complete list of every genetic variance that is affecting how rapidly the disease develops."

That, in turn, could help physicians figure out how to better treat patients.

More information

Learn more about AIDS from AIDS.gov.



SOURCES: Mary Carrington, Ph.D., senior principal investigator, National Cancer Institute, Frederick, Md.; Rowena Johnston, Ph.D., vice president, research, Foundation for AIDS Research, New York City; Nov. 22, 2009, Nature Genetics, online


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Genetic changes shown to be important indicators for disease progression in cervical cancer patients
2. Cleveland Clinic Cancer Geneticist Charis Eng, M.D., Ph.D., Named To Federal Advisory Committee
3. Research Findings Key for Understanding, Interpreting Genetic Testing for Long QT Syndrome
4. Geneticists hunt for scleroderma triggers
5. Researchers exploit genetic co-dependence to kill treatment-resistant tumor cells
6. Research partnership will study how electronic medical records can address genetics of drug safety
7. Are Commercial Genetic Tests Worth Taking?
8. Genetics of patterning the cerebral cortex
9. Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings
10. Ironing out the genetic cause of hemoglobin problems
11. Feinstein Investigators Receive Federal GO Grant to Study the Genetics of Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, ... guideline updates for the primary prevention of cardiovascular diseases during the 15th ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Ellevate Network, the ... business to advocate for action towards gender equality at their inaugural Summit in New ... the globe, and reached a social audience of over 3 million. To watch the ...
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the Los ... article to the newly revamped Cosmetic Town journal section, featuring articles ... procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi says ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Mich. , Oct. 2, 2017 Diplomat ... 8th Day Software and Consulting, LLC , and ... 8th Day Software, based in Tennessee ... LLC. 8th Day expands EnvoyHealth,s service offerings for health ... development. "In an ...
(Date:10/2/2017)... 2017  AllianceRx Walgreens Prime, the combined central specialty ... pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially ... the unveiling of new signage at its headquarters in ... at a few other company-owned facilities across the country. ... some of whom will begin to see the AllianceRx ...
(Date:10/2/2017)... Denmark , Oct. 2, 2017 The Rebound ... in the struggle to reverse the tide of prescription drug ... for regulating their medicine intake and stepping down their dosage ... set to launch in December 2017; the first 100,000 people ... Learn more at http://www.rebound-solution.com/ ...
Breaking Medicine Technology: